Please enable JavaScript to view the site.

About Deloitte
Contact us
Location: Global

Services
What's New
Audit & Assurance

IASPlus

Consulting

Human Capital

Strategy & Operations

Technology

Risk Advisory

Strategic & Reputation Risk

Regulatory Risk

Financial Risk

Operational Risk

Cyber Risk
Financial Advisory

Mergers & Acquisitions

Restructuring Services

Deloitte Forensic

Legal

Deloitte Legal around the world

Dbriefs Legal

Deloitte Legal services

Tax

Global Business Tax

Global Employer Services

Global Tax Reset
Industries
What's New
Consumer

Automotive

Consumer Products

Retail, Wholesale & Distribution

Transportation, Hospitality & Services

Energy, Resources & Industrials

Industrial Products & Construction

Mining & Metals

Oil, Gas & Chemicals

Power & Utilities

Future of Energy

Financial Services

Banking & Capital Markets

Insurance

Investment Management

Real Estate
Government & Public Services

Civil Government

Defense, Security & Justice

Health & Social Care

International Donor Organizations

Transport

Life Sciences & Health Care

Health Care

Life Sciences

Technology, Media & Telecommunications

Technology

Telecommunications, Media & Entertainment
Careers
What's New
- Millennial Survey 2019
  Optimism and trust reach troubling low levels
- Alumni profiles
  Inspiring leaders
Job search

Experienced hires

Students

Life at Deloitte

Alumni

Life Sciences & Health Care

The Life Sciences & Health Care industry group strives to support clients in addressing the challenges that impact today’s industry. Deloitte member firms' global network engages with clients to develop innovative solutions to help them achieve their business missions.

Life Sciences
Health Care

All
Solutions
People

Deloitte Insights

Forces of change in health care

The future of health

The future of health will likely be driven by digital transformation enabled by radically interoperable data and open, secure platforms.

Article

Platforms and Ecosystems

Enabling the Digital Economy

This whitepaper, part of the World Economic Forum's "Shaping the Future of the Digital Economy and Society initiative," looks at six key dimensions that determine whether digital platforms can retain public trust and governance and how they can revamp public-private collaboration for the same.

Perspectives

Digital transformation in life sciences

How pharma and medtech can shift from doing digital to being digital

Perspectives

Enabling smart health care with a modern analytics architecture

Tackling the global challenge of non-communicable diseases

Events

Financial Times US Pharma and Biotech Summit

Join us on 14 May 2019 at Convene - 605 Third Avenue, New York

Analysis

2019 Global life sciences outlook

Focus and transform| Accelerating change in life sciences

The evolving industrialization of life sciences will affect all aspects of how companies work to meet consumer expectations. Learn more in the outlook for 2019.

Article

The future of Life Sciences and Health Care in Asia Pacific

Embrace, Build and Grow

Article

Embracing the future of work to unlock R&D productivity

Measuring the return from pharmaceutical innovation 2018

The biopharma industry continues to face challenges this year, with projected returns on investment in R&D at the lowest levels since our analysis began in 2010. Can this trend be reversed?

Analysis

2019 Global Health Care Outlook

Shaping the future

With financial sustainability, care delivery, patient centricity, digital transformation, and regulatory compliance at the top of the agenda, health care sector leaders need to collaborate with all stakeholders—both within the health care ecosystem and those in converging industries.

Article

Medtech and the Internet of Medical Things

How connected medical devices are transforming health care

New research from Deloitte UK Centre for Health Solutions examines how the IoMT is transforming medtech’s role in health care. It outlines how medtech companies can get digital transformation right – whether through adapting their existing business models, inventing new ones or both.

Article

A bold future for life sciences regulation

Predictions 2025

A special look at how life sciences regulation is evolving from a barrier to an accelerator of innovation.

Events

Webinar: Future of life sciences regulation

Today’s increasingly complex and fragmented life sciences regulatory landscape is struggling to keep pace with the exponential changes in medicine, science and technology while protecting patient safety.

Perspectives

Video: Artificial intelligence in health care

Deloitte’s Dr. Matt Howard and Dr. Ronen Gordon give insights into how artificial intelligence engines are helping health care systems to address some productivity challenges by analyzing reams of unstructured data.

Deloitte Insights

How do health care consumers and doctors perceive virtual care?

Our 2018 survey results show an interesting juxtaposition

Virtual health care is popular—in theory. Deloitte surveys of US physicians and health care consumers found support for the concept, but doctors aren’t meeting demand. However, organizations that get on board sooner rather than later may see the benefits.

Perspectives

A life sciences and health care perspective: Tech Trends 2018

Technology trends transforming the future of life sciences and health care

Events

2019 J.P. Morgan Health Care Investor Conference

Explore Deloitte's M&A life sciences and health care leadership presence and topical discussions concurrent to the J.P. Morgan Health Care Investor Conference.

Deloitte Insights

Survey finds biopharma companies lag in digital transformation

It is time for a sea change in strategy

Here’s how companies can take an enterprisewide approach to digital transformation—including strategic changes to leadership and talent, as well as funding.

Deloitte Insights

The future of real-world evidence

A focus on end-to-end, AI-driven, internally developed solutions

Article

Future of business interaction

A study on the interaction between MedTech companies and hospitals

With this study, we shine a spotlight on the challenges in business interactions today. We aim to drive forward the discussion among stakeholders so as to find solutions that can be applied broadly, yielding benefits for all parties involved.

Predictions

The future awakens

Life Sciences and Health Care Predictions 2022

The year is 2022. The quantified self is alive and well, digital technologies have transformed the culture of health care and new entrants have disrupted delivery models. These are some of our predictions that, if they come true, will shake up the life sciences and health care industry.

Article

EU Clinical Trial Regulation

Building a successful program

The implementation of the new European Union (EU) Clinical Trial Regulation will provide a unified portal and database for trial sponsors and regulatory agencies across the EU Member States, promising to bring greater regulatory convergence and efficiency to the clinical trial application process.

Article

Time to care

Securing a future for the hospital workforce in Europe

In light of rising demand, staff shortages and lack of time for hands-on-care, is the current hospital workforce model sustainable? New research released by the Deloitte UK Centre for Health Solutions explores the current state of hospital workforces across Europe and their key challenges.

Article

Regulation in Life Sciences

Turning complexity into opportunity

Stay ahead of the curve when it comes to regulatory policy in Life Sciences. Here you'll find a range of tools on a variety of topics from around the globe that provide critical insight and advice, helping you to anticipate change and plan ahead.

Perspectives

The digital hospital of the future

In 10 years, technology may change the face of global health care delivery

Learn how the digital hospital of the future can leverage technology to transform the future of health care delivery, including digital patient experience in this report developed by Deloitte US.

Deloitte Insights

Strategies for stemming the opioid epidemic

How analytics can aid health plans and PBMs

The opioid crisis in the United States continues to reverberate across society. While a holistic solution remains elusive, health plans and pharmacy benefit managers are evolving their use of data analytics and technology to improve prevention and treatment among their members and in their communities.

Article

Breaking the dependency cycle

How health inequalities of vulnerable families can be tackled in Western Europe

Analysis

Pharma and the connected patient

How digital technology is enabling patient centricity

New research released by the Deloitte UK Centre for Health Solutions explores how digital technology can help pharma embrace patient centricity to remain relevant, profitable, and to deliver better health outcomes.

Article

Unravelling complexity

The challenge of compliance in the life sciences supply chain

Article

The bigger picture

Impact of EU regulatory change on the global life sciences industry

Article

2017 Pharmaceutical R&D leader survey

Innovating to survive, collaborating to thrive

Article

Under the spotlight

Data integrity in life sciences

Regulatory bodies now have high expectations with regard to data quality and integrity owing to the life sciences industry’s growth, globalization and adoption of advanced technology, such as highly automated systems and storage of data in ‘The Cloud’. Read the report to learn more.

Article

High-value health care

Innovative approaches to global challenges

What are pioneering health care providers, health plans, and life science companies doing to anticipate patient needs, reduce costs, and improve overall health outcomes in the US and globally? Learn more in this new Deloitte Center for Health Solutions research.

idmp standards and timeline

Article

Identification of Medicinal Products

Connecting the parts

The potential benefits of meeting the evolving Identification of Medicinal Product (IDMP) requirements extend far beyond regulatory compliance. Learn more here.

Article

Leadership perspectives

Insights on today’s hot topics in life sciences and health care

Analysis

Collaboration meets innovation

Executive perspectives on provider-sponsored health plans

Health care executives weigh in on what health care providers and health plans need to know before entering into a provider-sponsored health plan partnership.

Article

Identification of Medicinal Products

Think Transformation

Identification of Medicinal Products (IDMP) is one the biggest regulatory challenges for all pharmaceutical companies operating in Europe. How can your organisation navigate this journey towards increased patient safety and use it as an opportunity for business transformation?

Article

Facing the tidal wave

De-risking pharma and creating value for patients

The pharmaceutical industry is facing a ‘tidal wave’ of complex age and behaviour-related diseases creating increased economic, scientific and delivery risks. How can pharma companies evolve to overcome these obstacles?

Article

Preparing for the future

The new European Union medical devices regulation

Perspectives

Join the conversation

Social media connections to Deloitte's LSHC practice

Analysis

Top 10 health care innovations

More value, better outcomes, for less

Survey of health care leaders explores the top 10 health care innovations. What innovations may provide more value and transform the industry?

Article

Vital Signs

How to deliver better healthcare across Europe

In this report by the Deloitte UK Centre for Health Solutions, we identify 7 markers of a strong healthcare system and explore how these can be used to transform healthcare delivery across Europe.

Contact us

Contact us via our online form

Services

Deloitte U.S. Center for Health Solutions

The health services research arm of Deloitte United States.
Deloitte UK Centre for Health Solutions

The health services research arm of Deloitte United Kingdom.
Life sciences supply chain

Helping to optimize, reinvent and improve supply chains for companies across the pharmaceutical, biotechnology and medical device industries. Read to learn more.
Global Salesforce Assets & Solutions Group

Harness the power of industry-specific extensions to the Salesforce platform designed to solve real issues and deliver tangible value.
Deloitte Analytics

Life Sciences and Healthcare Learn how Deloitte member firms are helping organizations link business strategy to advanced analytical techniques to improve decision-making capabilities.

Similar topics

Life Sciences and Health Care

Greg Reh

Deloitte Global Life Sciences & Health Care Leader

grreh@deloitte.com

+1 215 977 7559

Stephanie Allen

Global Public Health & Social Services Leader

steallen@deloitte.com.au

+61 02 9322 3118

Get In Touch Author Host Panel

What do you think?

Join the conversation on Twitter

Contact us
Submit RFP
Job search

Get Connected

Newsroom
Social media
Leadership blog
Press releases
Submit an RFP
Job Search
Global office directory
Contact us
Newsroom jump | Deloitte

Services

Audit & Assurance
Consulting
Risk Advisory
Financial Advisory
Legal
Tax

Industries

Consumer
Energy, Resources & Industrials
Financial Services
Government & Public Services
Life Sciences & Health Care
Technology, Media & Telecommunications

Careers

Job search
Experienced hires
Students
Life at Deloitte
Alumni

Legal

About Deloitte
Terms of use
Cookies
Privacy
Privacy Shield
Accessibility statement

© 2019. For information, contact Deloitte Touche Tohmatsu Limited.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited (“DTTL”), its global network of member firms, and their related entities. DTTL (also referred to as “Deloitte Global”) and each of its member firms are legally separate and independent entities. DTTL does not provide services to clients. Please see www.deloitte.com/about to learn more.